HIGH RISK CHRONIC MYELOMONOCYTIC LEUKEMIA

Clinical trials for HIGH RISK CHRONIC MYELOMONOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new HIGH RISK CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for HIGH RISK CHRONIC MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New chemo combo tested for Tough-to-Treat blood cancers

Disease control Recruiting now

This early-stage study is testing a new chemotherapy combination called CPX-351 in adults with high-risk myelodysplastic syndrome or chronic myelomonocytic leukemia that has come back or hasn't responded to standard treatments. The main goals are to find the safest dose and under…

Matched conditions: HIGH RISK CHRONIC MYELOMONOCYTIC LEUKEMIA

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 01, 2026 23:26 UTC

HIGH RISK CHRONIC MYELOMONOCYTIC LEUKEMIA

Get alerted when new HIGH RISK CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

New chemo combo tested for Tough-to-Treat blood cancers